antipyrine has been researched along with niacin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (81.82) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| MODESTI, P; PARRAVICINI, M | 1 |
| DZIUBA, K | 1 |
| ANSARI, PM; EDER, H; PREUSSER, G; RAMMNER, U | 1 |
| PAPE, J; SCHMIDT, W | 1 |
| HARWERTH, HG; SCHMITT, HE | 1 |
| HIEMEYER, V | 1 |
| HARTERT, I | 1 |
| BATISWEILER, T; KREISELMAIER, G; MATHIES, H; WILL, E | 1 |
| Breger, G; Kingreen, JC | 1 |
11 other study(ies) available for antipyrine and niacin
| Article | Year |
|---|---|
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
[Clinical observations on the use of 4-nicotinamido-1, 5-dimethyl-2-phenyl-3-pyrazolone as analgesic and antirheumatic agent].
Topics: Analgesics; Antipyrine; Antirheumatic Agents; Neuralgia; Niacin; Pyrazolones; Rheumatic Diseases; Sciatica | 1959 |
[Treatment of rheumatic diseases and degenerative joint diseases with 4-(N-nicotinoylaminoacetylamino)-1-phenyl-2,3-dimethyl-pyrazolone-(5) HCl].
Topics: Antipyrine; Joint Diseases; Niacin; Nicotinic Acids; Pyrazolones; Rheumatic Diseases | 1961 |
[On the pharmacology of 4-(N-nicotinoylaminoacetylamino)-1-phenyl-2,3-dimethyl-pyrazolone-(5) HCI].
Topics: Antipyrine; Niacin; Nicotinic Acids; Pyrazolones | 1961 |
[Experiences in the treatment of concomitant rheumatic disorders in tuberculotics].
Topics: Antipyrine; Niacin; Nicotinic Acids; Prednisone; Rheumatic Diseases; Tuberculosis | 1961 |
[Studies on the levels of 4-(N-nicotinoylamino)-1-phenyl-2,3-dimethyl-pyrazolone-(5) in blood].
Topics: Antipyrine; Niacin; Nicotinic Acids; Pyrazolones | 1961 |
[Comparative studies on the antiphlogistic effect of nicotinoamide-phenyl-dimethylpyrazolone and its combination with prednisone].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Antipyrine; Humans; Inflammation; Niacin; Niacinamide; Prednisolone; Prednisone | 1963 |
[Practical experiences with 4-nicotinamido-2,3-dimethyl-l-phenyl-5-pyrazolone (nicopyron)].
Topics: Antipyrine; Niacin; Niacinamide; Nicotinic Acids; Pyrazolones | 1959 |
[Animal experimental studies on the hyaluronidase-inhibiting effects of nicotinamido-phenyldimethylpyrazolone].
Topics: Animals; Antipyrine; Hyaluronoglucosaminidase; Niacin; Nicotinic Acids | 1960 |
[Pellagra in morazone abuse].
Topics: Adult; Analgesics, Opioid; Antipyrine; Chemical and Drug Induced Liver Injury; Female; Humans; Male; Pellagra | 1984 |